Royal Bank of Canada
MIST icon

Royal Bank of Canada’s Milestone Pharmaceuticals MIST Stock Holding History

Royal Bank of Canada’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Hold
6,698
– – ﹤0.01% 6258
2025
Q4 		$13K Sell
6,698
-136,702
-95% -$294K ﹤0.01% 6290
2025
Q3 		$287K Buy
143,400
+107,800
+303% +$190K ﹤0.01% 4860
2025
Q2 		$69K Buy
35,600
+25,600
+256% +$34.1K ﹤0.01% 5779
2025
Q1 		$8K Buy
+10,000
New +$19.9K ﹤0.01% 6228
2024
Q4 		– Sell
-800
Closed -$1K – 7101
2024
Q3 		$1K Buy
+800
New +$1.16K ﹤0.01% 6724
2023
Q1 		– Sell
-2,000
Closed -$8K – 7318
2022
Q4 		$8K Hold
2,000
– – ﹤0.01% 6614
2022
Q3 		$18K Sell
2,000
-16,500
-89% -$125K ﹤0.01% 6188
2022
Q2 		$114K Sell
18,500
-8,002
-30% -$49.2K ﹤0.01% 5238
2022
Q1 		$170K Buy
26,502
+499
+2% +$3.12K ﹤0.01% 5228
2021
Q4 		$170K Sell
26,003
-192
-0.7% -$1.15K ﹤0.01% 5489
2021
Q3 		$149K Buy
26,195
+25,996
+13,063% +$147K ﹤0.01% 5418
2021
Q2 		$1K Sell
199
-104
-34% -$590 ﹤0.01% 7326
2021
Q1 		$2K Buy
303
+147
+94% +$1.08K ﹤0.01% 7244
2020
Q4 		$1K Buy
+156
New +$1.04K ﹤0.01% 6954

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Royal Bank of Canada's MIST Position: Q1 2026 in Review

Royal Bank of Canada held its Milestone Pharmaceuticals (MIST) position steady in Q1 2026 at 6,698 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #6258.

Royal Bank of Canada first reported a position in MIST in Q4 2020 and has held it in 15 quarters since. The position peaked at $287K in Q3 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Royal Bank of Canada held 6,698 shares of Milestone Pharmaceuticals worth $8K as of Q1 2026.
  • Royal Bank of Canada left its Milestone Pharmaceuticals share count unchanged in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6258 holding.
  • Royal Bank of Canada first reported a position in Milestone Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • Royal Bank of Canada's Milestone Pharmaceuticals position peaked at $287K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.